- A proposal for the adsorption of anastrozole anticancer drug on gold nanoparticle surfaces
Raïssa A.R. Teixeira et al, 2019, J Raman Spectrosc CrossRef - Androgen and breast cancer
Keely M. McNamara et al, 2016, Current Opinion in Endocrinology & Diabetes and Obesity CrossRef - The potential clinical benefit of targeting androgen receptor (AR) in estrogen-receptor positive breast cancer cells treated with Exemestane
Cristina Amaral et al, 2019, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef - In Vitro Systematic Drug Testing Reveals Carboplatin, Paclitaxel, and Alpelisib as a Potential Novel Combination Treatment for Adult Granulosa Cell Tumors
Joline Roze et al, 2021, Cancers CrossRef - The testosterone prescribing practice of BMS menopause specialists
A Scott et al, 2021, Post Reprod Health CrossRef - Differential biological effects of aromatase inhibitors: Apoptosis, autophagy, senescence and modulation of the hormonal status in breast cancer cells
Tiago V. Augusto et al, 2021, Molecular and Cellular Endocrinology CrossRef - Synthesis of trans N-Substituted Pyrrolidine Derivatives Bearing 1,2,4-
triazole Ring
Tangella Nagendra Prasad et al, 2022, COS CrossRef - In Vitro Effects of Combining Genistein with Aromatase Inhibitors: Concerns Regarding Its Consumption during Breast Cancer Treatment
Patrícia H. A. Bezerra et al, 2023, Molecules CrossRef - Individual Benefits and Risks of Intravaginal Estrogen and Systemic Testosterone in the Management of Women in the Menopause, With a Discussion of Any Associated Risks for Cancer Development
Abbie J. Laing et al, 2022, Cancer J CrossRef